Correction to “Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: A pharmacovigilance analysis of FAERS”

IF 5.7 2区医学 Q1 ONCOLOGY

International Journal of Cancer Pub Date : 2025-02-16 DOI:10.1002/ijc.35367

引用次数: 0

Abstract

Song Z, Wang Y, Zhang D, Wang T, Liu N, Gao L, Wang L, Yang J. Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: a pharmacovigilance analysis of FAERS. Int J Cancer. 2025;156(5):1033-1042. doi:10.1002/ijc.35235

In the article, Libing Wang was inadvertently removed from the list of corresponding authors and has been reinstated in the online version of the article. Therefore, the corresponding author details should read:

Libing Wang, Shanghai Changhai Hospital,168 Changhai Road, Shanghai, China.Email: [email protected]

Jianmin Yang, Shanghai Changhai Hospital,168 Changhai Road, Shanghai, China.Email: [email protected]

We apologize for this error.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Cancer 医学-肿瘤学

CiteScore

13.40

自引率

3.10%

发文量

460

审稿时长

2 months

期刊介绍： The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories: -Cancer Epidemiology- Cancer Genetics and Epigenetics- Infectious Causes of Cancer- Innovative Tools and Methods- Molecular Cancer Biology- Tumor Immunology and Microenvironment- Tumor Markers and Signatures- Cancer Therapy and Prevention